Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about JNJ

Recent news which mentions JNJ

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Tickers JNJ
Tags Options Benzinga JNJ
From Benzinga
Price Over Earnings Overview: Johnson & Johnson
Tickers JNJ NEWS
Tags News BZI/PE Intraday Update
From Benzinga
This Is What Whales Are Betting On Johnson & Johnson
Tickers JNJ
Tags Options Benzinga Markets
From Benzinga
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Tickers EME HQY JNJ NEWS
Tags EME Market News Analyst Ratings
From Benzinga
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Tickers AZN JNJ MRNA NEWS
Tags NVAX Donald Trump Markets
From Benzinga
Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day?
Tickers COST ISRG JNJ KO
Tags VDC JNJ VPU
From Motley Fool
Johnson & Johnson Challenges Government Drug Pricing Dispute Over Two Drugs
Tickers JNJ NEWS
Tags JNJ Stories That Matter General
From Benzinga
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Tickers ABT JNJ
Tags Recent Press Releases Market News ABT
From Motley Fool
Industry Comparison: Evaluating Johnson &amp; Johnson Against Competitors In Pharmaceuticals Industry
Tickers JNJ NEWS
Tags Benzinga Trading Ideas News
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Tickers JNJ MDT NEWS RPRX
Tags MDT health care Market News
From Benzinga
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Tickers JNJ MYCOF NEWS PFE
Tags Health Care Psychedelics Market News
From Benzinga
Johnson & Johnson's Tremfya Seeks Expanded Use Approval After It Shares Encouraging Late-Stage Study Data In Crohn's Disease
Tickers JNJ NEWS
Tags Top Stories Market News JNJ
From Benzinga
3 Dividend Growth Stocks You Can Buy and Hold Forever
Tickers ABBV ABT JNJ
Tags ABBV Recent Press Releases JNJ
From Motley Fool
Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas
Tickers JNJ NEWS
Tags Benzinga Top Stories Market News
From Benzinga
Comparative Study: Johnson &amp; Johnson And Industry Competitors In Pharmaceuticals Industry
Tickers JNJ NEWS
Tags Benzinga Trading Ideas News
From Benzinga
Meet the Only 2 Game-Changing Businesses With a Higher Credit Rating Than the U.S. Government
Tickers JNJ MSFT
Tags Recent Press Releases MSFT Market News
From Motley Fool
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
Tickers AAPL ABBV AMZN AVGO
Tags AAPL LLY V
From Motley Fool
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock
Tickers BIIB JNJ LLY
Tags Market News JNJ LLY
From Motley Fool
Justice Department's Trustee Program Alleges Johnson & Johnson's Talc Litigation Bankruptcy Bid Is Bad-Faith Tactic To Avoid Liability
Tickers JNJ NEWS
Tags Market News Benzinga Biotech
From Benzinga
Peering Into Johnson & Johnson's Recent Short Interest
Tickers JNJ
Tags Short Ideas BZI/SHORTHIST JNJ
From Benzinga
What's Going On With Kenvue Stock Monday?
Tickers HLN JNJ KVUE NEWS
Tags Benzinga KVUE HLN
From Benzinga
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Tickers JNJ KVUE NEWS
Tags News Equities Kaustubh Bagalkote
From Benzinga
All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year
Tickers CVX DJI DOW JNJ
Tags DOW Recent Press Releases ^DJI
From Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Tickers ABT JNJ
Tags JNJ ABT Market News
From Motley Fool
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
Tickers JNJ NEWS TYRA
Tags Analyst Ratings Market News Benzinga
From Benzinga
Johnson & Johnson Unusual Options Activity
Tickers JNJ
Tags Market News JNJ BZI/UOA
From Benzinga
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Tickers ABT JNJ PFE
Tags JNJ ABT Market News
From Motley Fool
This Magnificent Dividend Stock Is as Healthy as It Gets
Tickers JNJ
Tags Market News JNJ Recent Press Releases
From Motley Fool
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Tickers JNJ NEWS
Tags Large Cap Biotech Health Care
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags BMY Recent Press Releases JNJ
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.